Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT02798913

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02798913
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02798913. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2020-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD
Acronym
LONGDAPTPAD
Condition
Peripheral Artery Disease
Intervention (Drug)
Short DAPT
Intervention (Drug)
Long DAPT
Lead sponsor
Federico II University (class: other)

Record details

Record id
cardio:ct-nct02798913
Content hash
d25421fa188e0b3b5cdf26a72abc020819b1a658d893f375d06ce13db872f756